However, none of our current therapies have the capacity to regenerate cells that are damaged or lost.” “Our therapies for COPD focus on opening up the airways and reducing inflammation. “The concept of stem cell therapy has great potential,” says MeiLan King Han, MD, an associate professor of pulmonary medicine at the University of Michigan in Ann Arbor and a spokesperson for the American Lung Association. The company will likely soon begin to partner with a variety of pulmonologists to expand its treatment, says St. Regenerative Medicine Solutions has several ongoing clinical studies, as well as an application pending with the National Institutes of Health and pending Joint Commission accreditation. Those stem cells and growth factors will then be effective at reducing inflammation.” “We have coined the phrase the ‘pulmonary trap,’ which essentially captures the stem cells where they are most needed in the patient’s body. “When the stem cells are administered through an IV, they pass through a pulmonary track,” St Louis explains. The primary focus of treatment is to reduce the inflammation of the lungs. We have seen as much as a 60% improvement in pulmonary function.” “We, of course, see a higher level of success for people who are earlier on in their COPD diagnosis. “COPD has a number of different stages,” St. “There are also scientific measurements, including an improvement in pulmonary function in many patients.”Īdditionally, approximately 25% of patients elect follow-up treatments, spaced six months apart. “About 85% of our patients report an improvement in their quality of life, which includes anecdotally being happier, walking up the stairs, riding a horse, and going on bike rides,” St. Treatment is scheduled over two consecutive days and each session lasts 15 to 30 minutes. Stem cells are harvested from either the patient’s blood or bone marrow, then isolated, reconcentrated and readministered onsite through an IV. “We also believe that our ability to reduce the patient’s inflammation and reduce the symptoms of COPD is the future of COPD treatment.”
Louis, CEO of Regenerative Medicine Solutions, a medical management company in the field of regenerative medicine. Louis“We believe stem cell therapy is the first breakthrough in pulmonary medicine in a long, long time,” says Jimmy St.
Since 2013, more than 5,000 patients have received autologous stem cell therapy at Regenerative Medicine Solutions’ Lung Institute clinics. Autologous stem cell therapy may offer hope for patients with chronic obstructive pulmonary disease (COPD).Īn autologous transplant-or rescue-is a type of transplant that uses the person's own stem cells.
0 kommentar(er)
